Drawing for SPREMA

USPTO serial 78316832

SPREMA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BROWN, BRIAN
Law office
TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SPREMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005In your office action, you stated: 'And with pharmaceutical preparations and similar substances, the applicant must specify, the disease, condition or ailment that the goods are used to treat; TMEP §§1402;01 and 1402;03(a); In addition, the applicant must specify what "gemmotherapeutic" means; As a suggestion therefore, the applicant may adopt the following identification, if accurate: Pharmaceutical and veterinary preparations, namely, herbal and homeopathic preparations and substances used to treat applicant must specify the condition or disease to be treated, e;g;, cancer, indigestion, diabetes, in International Class 005'; The suggested identification is certainly accurate and could be used as such; However, to be more precise, gemmotherapy is a branch of herbal medicine that uses remedies made from the buds and young shoots of trees and shrubs, macerated in alcohol and glycerin and prepared in the 1DH homeopathic potency; This is what the word 'gemmotherapeutic' derives from - it is the adjective from the term 'gemmotherapy'; Gemmotherapy is widely used in parts of Europe but at present is little known in the USA - a search on the website will however reveal several sites that sell these products in America, as well as further information about the therapy itself; If possible, I would therefore like to include the term 'gemmotherapeutic' in the listing of goods; However, if it causes too many problems, it should be left out; Abies pectinata: osteoporosis, growing problems Acer campestris: gallstones, high blood pressure Actinidia chinensis: rheumatoid arthritis Aesculus hippocastanum: haemorrhoids Ailanthus altissima, buds: ulceration, sinusitis Ailanthus altissima, bark of young roots: dysentery Alnus glutinosa: strokes Alnus incana: fibrocystic breasts Ampelopsis veitchii: rheumatoid arthritis Berberis vulgaris: detoxification of liver and gallbladder Betula pubescens, bark of young roots: diuretic Betula pubescens, buds: detoxification of liver, gout Betula pubescens, catkins: low libido Betula pubescens, rootlets: raised cholesterol, diuretic Betula verrucosa, buds: rheumatism, fibrocystic breasts Betula verrucosa, sap: gout, kidney stones Betula verrucosa, seeds: memory loss Buddleja davidii: visual disturbances Calluna vulgaris: urinary tract infections Carpinus betulus: sinusitis Castanea vesca: haemorrhoids Cedrus libani: dry skin Cercis siliquastrum: thrombosis Citrus limonum, bark: angina Citrus limonum, buds: hyperacidity Cornus sanguinea: thrombosis Coryllus avellana: emphysema Crataegus oxycantha: angina Fagus sylvatica: water retention Ficus carica, buds: hyperacidity Ficus carica, rootlets: constipation Filipendula ulmaria: arthritis Fraxinus excelsior: glaucoma Fraxinus ornus: impotence Ginkgo biloba: strokes Hedera helix: obesity Hippophae rhamnoides: low resistance Ilex aquifolium: kidney deficiency Juglans regia: eczema Juniperus communis: liver problems Laurus nobilis: disorders of the gonads Ligustrum vulgare: bronchitis Lonicera nigra: hepatitis Magnolia denudata: upper respiratory tract infections Morus nigra: diabetes Olea europaea: hypertension Ostrya carpinifolia: sinusitis Pinus montana: osteoarthritis, rheumatism Pinus sylvestris: arthrosis Platanus orientalis: acne Populus nigra: thrombophlebitis Prunus amygdalus: hypertension Quercus pedunculata, buds: physical debility Quercus pedunculata, acorns: sexual debility Quercus pedunculata, catkins: loss of libido Quercus pedunculata, rootlets: bedsores, eczema Ribes nigrum: adrenal insufficiency Rosa canina: inflammations Rosmarinus officinalis: cirrhosis of the liver Rubus fruticosus: problems of the gonads Rubus idaeus: inflammation of the ovaries Salix alba, bark: arthritis Salix alba, buds: insomnia Salix alba, catkins: amenorrhoea Sanguisorba officinalis: diarrhoea Secale cereale: hepatitis Sequoia giganteum: prostatitis Silybum marianum: liver problems Sorbus domestica: venous insufficiency Sorbus torminalis: menopausal problems Syringa vulgaris: angina Tamarix gallica: problems of the spleen Thymus vulgaris: high cholesterol Tilia tomentosa: anxiety, insomnia Ulmus campestris: eczema, acne Vaccinium myrtillus: fragile capillaries Vaccinium vitis idaea: diarrhoea Viburnum lantana: asthma Vitis vinifera: arthritis Zea mays: heart attack Zizyphus jujuba, buds: insomnia, anxiety Zizyphus jujuba, seeds: memory and concentration lossACTIVEAug 2, 2003

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Mar 20, 2006MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 17, 2006ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 19, 2005GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 19, 2005CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 18, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 8, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 8, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 14, 2005GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 25, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Feb 9, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 9, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 9, 2005PETGPETITION TO REVIVE-GRANTED—
Feb 9, 2005PROATEAS PETITION TO REVIVE RECEIVED—
Dec 9, 2004MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 9, 2004ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 17, 2004EMRVEMAIL RECEIVED—
May 13, 2004UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
May 12, 2004GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2004DOCKASSIGNED TO EXAMINER—
Nov 5, 2003NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance